| Predicate |
Object |
| contentType |
Comment|Comparative Study|Journal Article |
| endingPage |
47 |
| issn |
1520-9156
1557-8593 |
| issueIdentifier |
1 |
| pageRange |
45-47 |
| publicationName |
Diabetes Technology & Therapeutics |
| startingPage |
45 |
| bibliographicCitation |
Cembrowski G. Alternate Site Testing: First Do No Harm. Diabetes Technology & Therapeutics. 2002 Feb;4(1):45–7. doi: 10.1089/15209150252924076. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d56c85081edaf0b2c998b643e4287812 |
| date |
200202 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/12017419
https://doi.org/10.1089/15209150252924076 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1557-8593
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21552
https://portal.issn.org/resource/ISSN/1520-9156 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Alternate Site Testing: First Do No Harm |
| discusses |
http://id.nlm.nih.gov/mesh/M0002696 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D003920Q000097
http://id.nlm.nih.gov/mesh/D005542Q000098
http://id.nlm.nih.gov/mesh/D015190Q000379
http://id.nlm.nih.gov/mesh/D001786Q000032
http://id.nlm.nih.gov/mesh/D005385Q000098 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D001364
http://id.nlm.nih.gov/mesh/D007003Q000209
http://id.nlm.nih.gov/mesh/D015203
http://id.nlm.nih.gov/mesh/D009928 |